Phylicia A Aaron (Phylicia Aaron)

Years Active: 2018-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Rodney P Rocconi, Erin E Stevens, Justin N Bottsford-Miller, Sharad A Ghamande, Jeffrey Elder, Leslie L DeMars, Adnan Munkarah, Phylicia A Aaron, Laura Stanbery, Gladice Wallraven, Ernest Bognar, Meghan Manley, Staci Horvath, Luisa Manning, Adam Walter, Evanthia Galanis, Thomas Herzog, Bradley J Monk, Robert L Coleman, John J Nemunaitis
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer. Cancer gene therapy (2021)
Elyssa Sliheet, Molly Robinson, Susan Morand, Khalil Choucair, David Willoughby, Laura Stanbery, Phylicia A Aaron, Ernest Bognar, John J Nemunaitis
Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy. Cancer gene therapy (2021)
Phylicia A Aaron, Mantana Jamklang, John P Uhrig, Angie Gelli
The blood-brain barrier internalises Cryptococcus neoformans via the EphA2-tyrosine kinase receptor. Cellular microbiology 20 (3) (2018)

Phylicia A Aaron.css-eqlu8i{font-size:small;padding-left:4px;} (Phylicia Aaron)